CBD消費者健康市場：成長、将来展望、競合分析、2024年～2032年

市場概要

CBD（カンナビジオール）は麻植物由来の天然化合物であり、近年消費者向け健康産業に大きく進出しています。いくつかの国ではまだ法制化の議論に巻き込まれていますが、その健康上の利点が謳われているため、外用クリームやオイルから摂取可能なカプセルやグミに至るまで、この化合物を配合した製品の市場が急成長しています。CBD消費者健康市場は、2024年から2032年にかけてCAGR 18.5％で成長すると推定されています。

CBD消費者健康市場力学

促進要因：健康効果による幅広い受容

消費者向け健康市場における CBD の台頭は、主にその使用に伴う健康上の利点の多さに起因しています。 多くの利用者が、CBD入り製品を摂取した後、不安の軽減、睡眠の改善、様々な慢性疼痛の緩和を経験していると報告しています。例えば、European Journal of Pain誌に掲載された研究では、CBDを皮膚に塗布することで、関節炎による痛みや炎症を抑える効果があることが実証されました。また、『Journal of Experimental Medicine』誌に掲載された別の調査では、一部のラットとマウスにおいて、CBDが慢性炎症と痛みを著しく軽減することが示唆されています。さらに、Journal of Clinical Psychology誌のレビューに記載されているように、不安障害に苦しむ人々がCBD投与後に緩和を発見しています。このように広く受け入れられ、消費者からの好意的なフィードバックが、市場拡大の大きな後押しとなっています。

ビジネスチャンス：スキンケアとウェルネス業界における統合の拡大

ウェルネス業界とスキンケア業界は、常に斬新で効果的な成分を求めています。CBDの抗炎症特性は、にきびや乾癬のような症状を治療するための有力な候補となります。Journal of Clinical Investigation誌に詳しく掲載された調査で、研究者たちはCBDが皮脂の分泌を抑える可能性があり、油分泌腺に対して抗炎症作用を持つことを発見しました。その結果、CBDをスキンケア製品に配合することで、治療法に革命を起こすことができます。さらに、スパやリラクゼーション業界を含むウェルネス分野では、CBDを配合したマッサージやセラピーが研究されており、消費者のリラクゼーション体験の向上が期待されています。

抑制：規制上の課題と混乱

CBD消費者健康市場が上昇軌道に乗る一方で、規制上の障害にも悩まされています。すべての政府が麻由来のCBDとマリファナを区別しているわけではなく、CBD製品の生産、販売、消費に規制がかかっています。例えば、2021年初頭、ニューヨーク・タイムズ紙の記事は、ニューヨークのいくつかのカフェや店舗がCBD入りの飲食品や飲料を販売しないよう警告を受けたことを取り上げ、このような製品の法的地位が曖昧であることを反映しています。

課題：市場の飽和と品質保証

CBDベースの製品の急速な普及は、多数のブランドや製剤による市場の飽和をもたらしました。このような選択肢の多さは、消費者にとって有益である一方で、製品の品質や一貫性に関する課題を提起しています。Journal of the American Medical Association誌は、オンラインで販売されているCBD製品の70％近くが、CBD含有量を過大に表示したり過小に表示したりして、誤った表示をしているという調査結果を発表しました。このような矛盾は消費者の信頼を損ない、市場の評判を下げ、潜在的な健康リスクをもたらす可能性があります。

製品別市場セグメンテーション

市場セグメンテーションでは、市場は医療用OTC製品と栄養補助食品に大別されます。医療用OTC製品は、不安、痛み、睡眠障害などの疾患の緩和を求める消費者によって牽引され、2023年の売上高では支配的なセグメントでした。オイル、カプセル、外用薬を含むこれらの製品は、治療目的でCBDを薦められたり、予備知識のある個人によって主に購入されました。特定の用量が保証され、病状に合致していることから、このセグメントは収益面で優位に立ちました。しかし、CBD入り食品サプリメントを含む栄養補助食品分野は、最も高いCAGRを示しています。この急増は、消費者が病気の緩和のためだけでなく、全体的な健康のためにCBD入りのお茶、グミ、その他の食用食品を取り入れている、毎日の健康習慣へのCBDの統合に起因しています。2032年までには、多様化と大衆への訴求力を持つ栄養補助食品分野が、医療用OTC製品を上回る売上になると予想されています。

流通チャネル別市場セグメンテーション

流通チャネルについては、2023年現在、小売薬局が市場収益の大部分を占めています。この優位性は、消費者が慣れ親しんだ評判の良い薬局から健康関連製品を購入することに安心感を抱くという信頼要素と関連付けることができます。さらに、薬剤師が用量や製品タイプについて指導する機会も重要な要因となっています。一方、オンラインストア部門は、2023年の売上高ではトップではありませんが、CAGRは最も高いです。オンライン・ショッピングの利便性が、より幅広い品揃えとユーザー・レビューと相まって、この成長を牽引しています。eコマースへのシフトは、パンデミックによる買い物習慣によってさらに加速しています。小売店は重要な役割を担っているものの、消費者が一般店舗で健康食品を購入することを選り好みしているため、伸びは比較的小さいです。2024年から2032年にかけては、デジタル・プラットフォームがより新しい消費者が利用する場所となり、オンライン・ストアがより大きな市場シェアを獲得すると予想されます。

地域別市場セグメンテーション

地域別では、規制が緩やかで消費者の意識が高い北米が2023年に最も高い売上を占めました。この地域は、CBD製品の早期導入と主流の健康・ウェルネス習慣への統合が極めて重要です。しかし、CAGRの点では、アジア太平洋地域が2024年から2032年までリードすると予想されています。日本や韓国など、CBD の利点に徐々に興味を持ち始めている国々と、これらの製品を知るようになった幅広い消費者層によって推進されています。

競合動向

競争面では、市場競争は活況を呈しています。2023年現在、Elixinol Global Limited、ENDOCA、NuLeaf Naturals LLC、Kazmira、Charlotte's Web、Joy Organics、Lord Jones、Medical Marijuana Inc.、CV Sciences Inc.、Isodiol International Inc.などの大手企業が、高品質の製品と効果的なマーケティング戦略でニッチを切り開いています。これらの企業の収益貢献は大きかったものの、2024年から2032年にかけては、新規参入企業が革新的な製品と積極的なデジタル・キャンペーンで市場を破壊すると予想されます。ウェルネス・インフルエンサーとの提携、ターゲットを絞ったデジタル広告、継続的な製品革新などの戦略が最前線に立つと予想されます。

本レポートでお答えする主な質問

CBD消費者健康市場の成長に影響を与えている主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントと地域に関する主な投資ポケットは？

2032年までの推定推計・市場予測

予測期間中にCAGRが最も速いセグメントは？

市場シェアの大きいセグメントとその理由は？

中低所得国はCBD消費者健康市場に投資しているか？

CBD消費者健康市場で最大の地域市場はどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は？

CBD消費者健康市場の成長を促進する主要動向は？

世界のCBD消費者健康市場で存在感を高めるための主要な競合企業とその主要戦略とは？

目次

第1章 序文

• レポート内容
  • レポートの目的
  • 対象者
  • 主なサービス
• 市場セグメンテーション
• 調査手法
  • フェーズⅠ- 二次調査
  • フェーズⅡ- 一次調査
  • フェーズⅢ- 有識者レビュー
  • 前提条件
  • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 CBD消費者健康市場：競合分析

• 主要ベンダーの市場ポジショニング
• ベンダーが採用した戦略
• 主要な産業戦略
• ティア分析：2023年 vs 2032年

第4章 CBD消費者健康市場：マクロ分析と市場力学

• イントロダクション
• 世界のCBD消費者健康市場金額 2022年～2032年
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
  • サプライヤーパワー
  • バイヤーパワー
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係
• PESTEL分析
  • 政治情勢
  • 経済情勢
  • テクノロジーの情勢
  • 法的な情勢
  • 社会情勢

第5章 CBD消費者健康市場：製品別 2022年～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2032年
• 市場セグメンテーション
  • 医療用OTC製品
    • CBD鎮痛剤
    • CBD皮膚科製品
    • CBDメンタルヘルス製品
    • CBD睡眠補助製品
    • その他のOTC製品
  • 栄養補助食品
    • CBDビタミンおよび栄養補助食品（VDS）
    • CBDスポーツ栄養
    • CBD体重管理と健康

第6章 CBD消費者健康市場：流通チャネル別 2022年～2032年

• 市場概要
• 成長・収益分析：2023年 vs 2032年
• 市場セグメンテーション
  • オンラインストア
  • 小売店
  • 小売薬局

第7章 北米のCBD消費者健康市場 2022年～2032年

• 市場概要
• CBD消費者健康市場：製品別 2022年～2032年
• CBD消費者健康市場：流通チャネル別 2022年～2032年
• CBD消費者健康市場：地域別 2022年～2032年
  • 北米
    • 米国
    • カナダ
    • その他北米地域

第8章 英国と欧州連合のCBD消費者健康市場 2022年～2032年

• 市場概要
• CBD消費者健康市場：製品別 2022年～2032年
• CBD消費者健康市場：流通チャネル別 2022年～2032年
• CBD消費者健康市場：地域別 2022年～2032年
  • 英国と欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他欧州地域

第9章 アジア太平洋のCBD消費者健康市場 2022年～2032年

• 市場概要
• CBD消費者健康市場：製品別 2022年～2032年
• CBD消費者健康市場：流通チャネル別 2022年～2032年
• CBD消費者健康市場：地域別 2022年～2032年
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第10章 ラテンアメリカのCBD消費者健康市場 2022年～2032年

• 市場概要
• CBD消費者健康市場：製品別 2022年～2032年
• CBD消費者健康市場：流通チャネル別 2022年～2032年
• CBD消費者健康市場：地域別 2022年～2032年
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域

第11章 中東・アフリカのCBD消費者健康市場 2022年～2032年

• 市場概要
• CBD消費者健康市場：製品別 2022年～2032年
• CBD消費者健康市場：流通チャネル別 2022年～2032年
• CBD消費者健康市場：地域別 2022年～2032年
  • 中東・アフリカ
    • GCC
    • アフリカ
    • その他中東・アフリカ地域

第12章 企業プロファイル

• Elixinol Global Limited
• ENDOCA
• NuLeaf Naturals LLC
• Kazmira
• Charlotte's Web
• Joy Organics
• Lord Jones
• Medical Marijuana Inc.
• CV Sciences Inc.
• Isodiol International Inc.
• その他の主要企業

List of Tables

• TABLE 1 Global CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 2 Global CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 3 Global CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 4 Global CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 5 North America CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 6 North America CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 7 North America CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 8 North America CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 9 U.S. CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 10 U.S. CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 11 U.S. CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 12 U.S. CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 13 Canada CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 14 Canada CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 15 Canada CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 16 Canada CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 17 Rest of North America CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 18 Rest of North America CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 19 Rest of North America CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 20 Rest of North America CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 21 UK and European Union CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 22 UK and European Union CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 23 UK and European Union CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 24 UK and European Union CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 25 UK CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 26 UK CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 27 UK CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 28 UK CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 29 Germany CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 30 Germany CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 31 Germany CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 32 Germany CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 33 Spain CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 34 Spain CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 35 Spain CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 36 Spain CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 37 Italy CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 38 Italy CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 39 Italy CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 40 Italy CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 41 France CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 42 France CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 43 France CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 44 France CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 45 Rest of Europe CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 46 Rest of Europe CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 47 Rest of Europe CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 48 Rest of Europe CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 49 Asia CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 50 Asia CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 51 Asia CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 52 Asia CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 53 China CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 54 China CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 55 China CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 56 China CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 57 Japan CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 58 Japan CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 59 Japan CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 60 Japan CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 61 India CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 62 India CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 63 India CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 64 India CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 65 Australia CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 66 Australia CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 67 Australia CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 68 Australia CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 69 South Korea CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 70 South Korea CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 71 South Korea CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 72 South Korea CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 73 Latin America CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 74 Latin America CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 75 Latin America CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 76 Latin America CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 77 Brazil CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 78 Brazil CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 79 Brazil CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 80 Brazil CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 81 Mexico CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 82 Mexico CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 83 Mexico CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 84 Mexico CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 85 Rest of Latin America CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 86 Rest of Latin America CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 87 Rest of Latin America CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 88 Rest of Latin America CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 89 Middle East and Africa CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 90 Middle East and Africa CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 91 Middle East and Africa CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 92 Middle East and Africa CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 93 GCC CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 94 GCC CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 95 GCC CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 96 GCC CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 97 Africa CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 98 Africa CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 99 Africa CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 100 Africa CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

• TABLE 101 Rest of Middle East and Africa CBD Consumer Health Market By Product, 2022-2032, USD (Million)
• TABLE 102 Rest of Middle East and Africa CBD Consumer Health Market By Medical OTC Products, 2022-2032, USD (Million)

TABLE 103 Rest of Middle East and Africa CBD Consumer Health Market By Nutraceuticals, 2022-2032, USD (Million)

TABLE 104 Rest of Middle East and Africa CBD Consumer Health Market By Distribution Channel, 2022-2032, USD (Million)

List of Figures

• FIG. 1 Global CBD Consumer Health Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global CBD Consumer Health Market: Quality Assurance
• FIG. 5 Global CBD Consumer Health Market, By Product, 2023
• FIG. 6 Global CBD Consumer Health Market, By Distribution Channel, 2023
• FIG. 7 Global CBD Consumer Health Market, By Geography, 2023
• FIG. 8 Market Geographical Opportunity Matrix - Global CBD Consumer Health Market, 2023

FIG. 9Market Positioning of Key CBD Consumer Health Market Players, 2023

FIG. 10Global CBD Consumer Health Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

• FIG. 11 Global CBD Consumer Health Market, By Product, 2023 Vs 2032, %
• FIG. 12 Global CBD Consumer Health Market, By Distribution Channel, 2023 Vs 2032, %
• FIG. 13 U.S. CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 14 Canada CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 15 Rest of North America CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 16 UK CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 17 Germany CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 18 Spain CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 19 Italy CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 20 France CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 21 Rest of Europe CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 22 China CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 23 Japan CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 24 India CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 25 Australia CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 26 South Korea CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 27 Rest of Asia CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 28 Brazil CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 29 Mexico CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 30 Rest of Latin America CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 31 GCC CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 32 Africa CBD Consumer Health Market (US$ Million), 2022 - 2032
• FIG. 33 Rest of Middle East and Africa CBD Consumer Health Market (US$ Million), 2022 - 2032

Market Overview

CBD, or cannabidiol, is a naturally occurring compound derived from the hemp plant and has been making significant inroads into the consumer health industry over recent years. While still embroiled in legislative discussions in several countries, its purported health benefits have created a burgeoning market for products infused with this compound, ranging from topical creams and oils to ingestible capsules and gummies. The CBD consumer health market is estimated to grow at a CAGR of 18.5% from 2024 to 2032.

CBD Consumer Health Market Dynamics

Driver: Widespread Acceptance due to Health Benefits

CBD's rise in the consumer health market can be primarily attributed to the plethora of health benefits associated with its use. Many users report experiencing reduced anxiety, improved sleep, and relief from various forms of chronic pain after consuming CBD-infused products. For instance, a study published in the European Journal of Pain demonstrated that CBD applied on the skin could help lower pain and inflammation due to arthritis. Another research, published in the Journal of Experimental Medicine, suggests that CBD can significantly reduce chronic inflammation and pain in some rats and mice. Furthermore, people suffering from anxiety disorders have found relief after CBD administration, as documented in a review from the Journal of Clinical Psychology. This widespread acceptance and positive feedback from consumers have provided a significant push for the market's expansion.

Opportunity: Growing Integration in Skincare and Wellness Industry

The wellness and skincare industries are always on the lookout for novel and effective ingredients. The anti-inflammatory properties of CBD make it a prime candidate for treating conditions like acne and psoriasis. In a study detailed in the Journal of Clinical Investigation, researchers found that CBD possesses the potential to reduce sebum production and has anti-inflammatory effects on oil-producing glands. As a result, the integration of CBD in skincare products can revolutionize treatment methods. Moreover, wellness sectors, including the spa and relaxation industry, are exploring CBD-infused massages and therapies, promising an enhanced relaxation experience for consumers.

Restraint: Regulatory Challenges and Confusion

While the CBD consumer health market witnesses an upward trajectory, it also grapples with regulatory roadblocks. Not all governments differentiate between hemp-derived CBD and marijuana, leading to restrictions on production, sale, or consumption of CBD products. For instance, in early 2021, an article from the New York Times highlighted how several cafes and stores in New York were warned against selling CBD-infused foods and beverages, reflecting the ambiguous legal status of such products.

Challenge: Market Saturation and Quality Assurance

The rapid proliferation of CBD-based products has led to a saturation of the market with numerous brands and formulations. This plethora of choices, while beneficial for consumers, poses challenges regarding product quality and consistency. The Journal of the American Medical Association published a study revealing that nearly 70% of CBD products sold online were mislabeled, either over-reporting or under-reporting the CBD content. This inconsistency can undermine consumer trust, dampen the market's reputation, and pose potential health risks.

Market Segmentation by Product

In terms of product segmentation, the market broadly bifurcates into Medical OTC Products and Nutraceuticals. Medical OTC Products were the dominant segment in 2023 in terms of revenue, driven by consumers seeking relief from ailments such as anxiety, pain, and sleep disorders. These products, including oils, capsules, and topicals, were predominantly purchased by individuals who had prior knowledge or were recommended CBD for therapeutic purposes. The assurance of specific doses and the alignment with medical conditions gave this segment a revenue edge. However, the Nutraceuticals segment, which encompasses CBD-infused food supplements, has been showing the highest CAGR. This surge is attributable to the integration of CBD into daily wellness routines, where consumers are incorporating CBD-infused teas, gummies, and other edibles not just for ailment relief but for overall well-being. By 2032, it's expected that the Nutraceuticals segment, with its diversification and mass appeal, might surpass Medical OTC Products in revenue.

Market Segmentation by Distribution Channels

Regarding distribution channels, as of 2023, Retail Pharmacies accounted for the lion's share of the market revenue. This dominance can be linked to the trust factor, where consumers feel assured purchasing health-related products from a familiar and reputed pharmacy. Moreover, the opportunity for pharmacists to guide on dosages and product types has been a crucial factor. Conversely, the Online Stores segment, although not the revenue leader in 2023, is witnessing the highest CAGR. The convenience of online shopping, coupled with a broader range of products and user reviews, has driven this growth. The shift to e-commerce has been further accelerated by the pandemic-induced shopping habits. Retail Stores, though playing a significant role, have seen a comparatively lesser growth, with consumers being selective about purchasing health products from general stores. From 2024 to 2032, Online Stores are expected to gain a more significant market share, with digital platforms becoming the go-to place for newer consumers.

Market Segmentation by Region

Geographically, North America, with its more relaxed regulations and high consumer awareness, accounted for the highest revenue in 2023. The region's early adoption and integration of CBD products into mainstream health and wellness routines have been pivotal. However, in terms of CAGR, the Asia-Pacific region is anticipated to lead from 2024 to 2032, driven by countries like Japan and South Korea that are gradually warming up to the benefits of CBD, combined with a vast consumer base getting introduced to these products.

Competitive Trends

On the competitive front, the CBD consumer health market has been bustling with activity. As of 2023, major players like Elixinol Global Limited, ENDOCA, NuLeaf Naturals LLC, Kazmira, Charlotte's Web, Joy Organics, Lord Jones, Medical Marijuana Inc., CV Sciences Inc., and Isodiol International Inc. had carved a niche with their quality products and effective marketing strategies. While these companies had significant revenue contributions, newer entrants are expected to disrupt the market with innovative products and aggressive digital campaigns from 2024 to 2032. Strategies such as partnerships with wellness influencers, targeted digital advertising, and continuous product innovation are anticipated to be at the forefront.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of CBD Consumer Health market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the CBD Consumer Health market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Product

• Medical OTC Products

• CBD Analgesic Products

• CBD Dermatology Products

• CBD Mental Health Products

• CBD Sleeping Aids Products

• Other OTC Products

• Nutraceuticals

• CBD Vitamins and Dietary Supplements (VDS)

• CBD Sports Nutrition

• CBD Weight Management and Wellbeing

Distribution Channel

• Online Stores

• Retail Stores

• Retail Pharmacies

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of CBD Consumer Health market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the CBD Consumer Health market?

Which is the largest regional market for CBD Consumer Health market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving CBD Consumer Health market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the CBD Consumer Health market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global CBD Consumer Health Market
• 2.2. Global CBD Consumer Health Market, By Product, 2023 (US$ Million)
• 2.3. Global CBD Consumer Health Market, By Distribution Channel, 2023 (US$ Million)
• 2.4. Global CBD Consumer Health Market, By Geography, 2023 (US$ Million)
• 2.5. Attractive Investment Proposition by Geography, 2023

3. CBD Consumer Health Market: Competitive Analysis

• 3.1. Market Positioning of Key CBD Consumer Health Market Vendors
• 3.2. Strategies Adopted by CBD Consumer Health Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2023 Versus 2032

4. CBD Consumer Health Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global CBD Consumer Health Market Value, 2022 - 2032, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2023 Versus 2032
• 5.3. Market Segmentation
  • 5.3.1. Medical OTC Products
    • 5.3.1.1. CBD Analgesic Products
    • 5.3.1.2. CBD Dermatology Products
    • 5.3.1.3. CBD Mental Health Products
    • 5.3.1.4. CBD Sleeping Aids Products
    • 5.3.1.5. Other OTC Products
  • 5.3.2. Nutraceuticals
    • 5.3.2.1. CBD Vitamins and Dietary Supplements (VDS)
    • 5.3.2.2. CBD Sports Nutrition
    • 5.3.2.3. CBD Weight Management and Wellbeing

6. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2023 Versus 2032
• 6.3. Market Segmentation
  • 6.3.1. Online Stores
  • 6.3.2. Retail Stores
  • 6.3.3. Retail Pharmacies

7. North America CBD Consumer Health Market, 2022-2032, USD (Million)

• 7.1. Market Overview
• 7.2. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
• 7.3. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
• 7.4.CBD Consumer Health Market: By Region, 2022-2032, USD (Million)
  • 7.4.1.North America
    • 7.4.1.1. U.S.
      • 7.4.1.1.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 7.4.1.1.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 7.4.1.2. Canada
      • 7.4.1.2.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 7.4.1.2.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 7.4.1.3. Rest of North America
      • 7.4.1.3.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 7.4.1.3.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)

8. UK and European Union CBD Consumer Health Market, 2022-2032, USD (Million)

• 8.1. Market Overview
• 8.2. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
• 8.3. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
• 8.4.CBD Consumer Health Market: By Region, 2022-2032, USD (Million)
  • 8.4.1.UK and European Union
    • 8.4.1.1. UK
      • 8.4.1.1.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 8.4.1.1.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 8.4.1.2. Germany
      • 8.4.1.2.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 8.4.1.2.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 8.4.1.3. Spain
      • 8.4.1.3.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 8.4.1.3.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 8.4.1.4. Italy
      • 8.4.1.4.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 8.4.1.4.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 8.4.1.5. France
      • 8.4.1.5.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 8.4.1.5.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 8.4.1.6. Rest of Europe
      • 8.4.1.6.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 8.4.1.6.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)

9. Asia Pacific CBD Consumer Health Market, 2022-2032, USD (Million)

• 9.1. Market Overview
• 9.2. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
• 9.3. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
• 9.4.CBD Consumer Health Market: By Region, 2022-2032, USD (Million)
  • 9.4.1.Asia Pacific
    • 9.4.1.1. China
      • 9.4.1.1.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 9.4.1.1.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.4.1.2. Japan
      • 9.4.1.2.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 9.4.1.2.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.4.1.3. India
      • 9.4.1.3.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 9.4.1.3.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.4.1.4. Australia
      • 9.4.1.4.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 9.4.1.4.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.4.1.5. South Korea
      • 9.4.1.5.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 9.4.1.5.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 9.4.1.6. Rest of Asia Pacific
      • 9.4.1.6.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 9.4.1.6.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)

10. Latin America CBD Consumer Health Market, 2022-2032, USD (Million)

• 10.1. Market Overview
• 10.2. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
• 10.3. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
• 10.4.CBD Consumer Health Market: By Region, 2022-2032, USD (Million)
  • 10.4.1.Latin America
    • 10.4.1.1. Brazil
      • 10.4.1.1.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 10.4.1.1.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.4.1.2. Mexico
      • 10.4.1.2.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 10.4.1.2.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 10.4.1.3. Rest of Latin America
      • 10.4.1.3.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 10.4.1.3.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)

11. Middle East and Africa CBD Consumer Health Market, 2022-2032, USD (Million)

• 11.1. Market Overview
• 11.2. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
• 11.3. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
• 11.4.CBD Consumer Health Market: By Region, 2022-2032, USD (Million)
  • 11.4.1.Middle East and Africa
    • 11.4.1.1. GCC
      • 11.4.1.1.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 11.4.1.1.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.4.1.2. Africa
      • 11.4.1.2.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 11.4.1.2.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)
    • 11.4.1.3. Rest of Middle East and Africa
      • 11.4.1.3.1. CBD Consumer Health Market: By Product, 2022-2032, USD (Million)
      • 11.4.1.3.2. CBD Consumer Health Market: By Distribution Channel, 2022-2032, USD (Million)

12. Company Profile

• 12.1. Elixinol Global Limited
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. ENDOCA
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. NuLeaf Naturals LLC
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. Kazmira
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Charlotte's Web
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. Joy Organics
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Lord Jones
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. Medical Marijuana Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. CV Sciences Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives
• 12.10. Isodiol International Inc.
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Portfolio
  • 12.10.4. Strategic Initiatives
• 12.11. Other Notable Players
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Portfolio
  • 12.11.4. Strategic Initiatives